نتایج جستجو برای: hepatitis b virus hbv

تعداد نتایج: 1260001  

HR Mollaei , MJ Zahedi , SAM Arabzadeh , Z Iranmanesh ,

Background and Aims: Viral hepatitis is a global health problem with a high mortality rate. Recently, a new Flavi-like virus, provisionally named hepatitis G virus (HGV), has been described. HGV does not induce an immune response that is consistently detectable by using recombinant proteins from prokaryotic expression, therefore studies have been conducted by using polymerase chain reaction (...

Journal: :iranian journal of virology 0
e fakhari azad university of zanjan, zanjan, iran m norouzi department of virology, tehran university of medical science, tehran, iran sm jazayeri department of virology, tehran university of medical science, tehran, iran

background and aims: lamivudine is amongst the antiviral for drug chronic hepatitis b treatment. during therapy with lamivudine, variants may emerge with ymdd mutation in the reverse transcriptase (rt) region of polymerase gene. this mutation might have a role in drug resistant for hbv. materials and methods: hbv dna extraction from serum sample of 88 patients, were subjected to nested pcr for ...

Journal: :iranian biomedical journal 0
süleyman onal selcuk kaya buket cicioglu aridogan emel sesli cetin emel sesli cetin buket cicioglu aridogan selcuk kaya süleyman onal mustafa demirci

the aim of this study was to investigate the prevalence of hepatitis b virus (hbv) genotypes in isparta, southwest of turkey, as well as the clinical features and transmission route for patients with hbv infections. methods: patients (n = 135) with hbv infection were included in the study. epidemiological and clinical data were obtained. hbv genotypes were determined with a pres2 epitope elisa ...

 Abstract Background: Investigators were suspicious of tyrosine-methionine-aspartate-aspartate (YMDD) mutations occurred only in patients who were treated by lamivudine. However, YMDD mutations of hepatitis B virus gene (HBV DNA) in patients with chronic hepatitis B (CHB) untreated with antiviral medicines was reported in some studies. The aim of this study was to evaluate YMDD mutations in Ira...

Ali Akbar Pourfathollah, Ali Dehghani Fard, Amir Mohammad Alborzi, Mohammad Ali Jalalifar, Mohammad Kazemi Arababadi, Mohammad Shahjahani, Najmaldin Saki, Omid Kiani Ghalesardi, Taravat Bamdad,

Background: Blood transfusion plays a great role in public health and the blood safety still has remained a main concern. HBV has been considered as one of the most prevalent blood borne infections. It is estimated that chronic HBV affects 350-400 million people worldwide. Comprehensive knowledge about HBV has high importance in Iran due to high number of blood dependent patients. Material ...

Alireza Ghazimorad, Majid Bouzari, Mohammad Taghi Kardi,

Background: Recently, some new viruses have been identified for their association with hepatitis which Torque Teno Mini Virus being among them. The aim of this study was to determine the frequency of Torque Teno Mini Virus in healthy individuals and hepatitis B and C patients in Isfahan, Iran. Materials and Methods: One hundred serum samples of healthy individuals from Isfahan Blood Transfusi...

H Zareei , MJ Zahedi , S Darvish-Moghaddam ,

Background and Aims: Hepatitis D virus (HDV) can infect human population either as a superinfection or concurrent hepatitis B virus (HBV) infection. It is expected that presence of HDV infection is more prevalent in endemic HBV areas. Overall 5% of Iranian general populations are chronic HBV carriers. The aim of this study was to determine the seroprevalence of HDV and its clinical impact in ...

With up to 400 million affected people worldwide, chronic hepatitis B virus (HBV) infection is still a major health care problem. During the last decade, several novel therapeutic approaches have been developed and evaluated. In most regions of the world, interferon-α (IFN-α), and nucleos(t)ide analogues are currently approved. Despite major improvements, none of the existing therapies is optim...

Journal: :Annals of internal medicine 2017
Susan J Bersoff-Matcha Kelly Cao Mihaela Jason S Christopher Jones Allen Brinker

Background: Direct-acting antiviral agents (DAAs) are used increasingly to treat hepatitis C virus (HCV) infection. Reports were published recently on hepatitis B virus (HBV) reactivation (HBV-R) in patients with HBV–HCV co-infection. Hepatitis B virus reactivation, defined as an abrupt increase in HBV replication in patients with inactive or resolved HBV infection, may result in clinically sig...

نیکپور, صغری,

Viral hepatitis is one of five infectional factors cause early death in all over the world. Every day at least one million people die because of viral hepatitis. Six hepatitis viruses have been known until now. They are A, B, C, D, E, G, and it is probable that at least two other kinds i.e. F, and H, will be known soon. Only hepatitis B is a DNA virus, and the others are RNA viruses. All viruse...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید